Tjerk J. Opstal
Alkmaar, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The Effect of Low-Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double-Blind Randomized Placebo-Controlled Cross-Over Study.
Journal: Clinical pharmacology and therapeutics
Published: April 11, 2024
Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have?
Journal: Frontiers in cardiovascular medicine
Published: December 07, 2023
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial.
Journal: Frontiers in cardiovascular medicine
Published: June 22, 2023
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 15, 2023
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial.
Journal: Clinical drug investigation
Published: September 26, 2022
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
Journal: International journal of cardiology
Published: September 14, 2022
Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
Journal: Circulation
Published: February 21, 2022
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
Journal: Journal of the American College of Cardiology
Published: May 10, 2021
Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: March 13, 2021
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
Journal: European heart journal
Published: February 11, 2021
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
Journal: Atherosclerosis
Published: February 04, 2021
Last Updated: 09/26/2026